CAS 1624602-30-7

Formel: C19H16ClN5O6S

InChl: InChI=1S/C19H16ClN5O6S/c20-13-1-3-15-16(11-13)21-6-5-17(15)22-7-9-23(10-8-22)32(30,31)19-4-2-14(24(26)27)12-18(19)25(28)29/h1-6,11-12H,7-10H2

InChI Key: PDQVZPPIHADUOO-UHFFFAOYSA-N

SMILES: C1CN(CCN1C2=C3C=CC(=CC3=NC=C2)Cl)S(=O)(=O)C4=C(C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-]

Quinoline, 7-chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]-

CAS: 1624602-30-7

Formel: C₁₉H₁₆ClN₅O₆S

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 477.8782

Ref: IN-DA001T5R

VR23

CAS: 1624602-30-7

VR23

Formel: C₁₉H₁₆ClN₅O₆S

Reinheit: ≥98%

Molekulargewicht: 477.88

Ref: 54-OR1023366

VR23

CAS: 1624602-30-7

VR23

Formel: C₁₉H₁₆ClN₅O₆S

Reinheit: 99%

Molekulargewicht: 477.88

Ref: 54-BUP11062

VR23

CAS: 1624602-30-7

VR23: Potent proteasome inhibitor; IC50: 1 nM trypsin, 50-100 nM chymotrypsin, 3 μM caspase-like.

Formel: C₁₉H₁₆ClN₅O₆S

Reinheit: 98.99% - 99.22%

Farbe und Form: White Solid

Molekulargewicht: 477.878

Ref: TM-T7016

VR23 [Proteasome Inhibitor]

CAS: 1624602-30-7

Ref: 7W-GW0993

VR23

CAS: 1624602-30-7

7-Chloro-4-(4-((2,4-dinitrophenyl)sulfonyl)piperazin-1-yl)quinoline

Formel: C₁₉H₁₆ClN₅O₆S

Reinheit: 99%

Molekulargewicht: 477.88

Ref: IN-DG583814

Quinoline, 7-chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]-

CAS: 1624602-30-7

Reinheit: 99%

Molekulargewicht: 477.8800049

Ref: 10-F865719

7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8

Kontrolliertes Produkt

CAS: 1624602-30-7

Applications 7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8 is a Quinoline-Sulfonyl Hybrid Proteasome Inhibitor used to treat cancer.
References Pundir, S., et al.: Cancer Research, 75, 4164 (2015);

Formel: C₁₉H₈D₈ClN₅O₆S

Farbe und Form: Neat

Molekulargewicht: 485.93

Ref: TR-C377562

4-((4-(7-Chloroquinolin-4-yl)piperazin-1-yl)sulfonyl)-3-nitroaniline

Kontrolliertes Produkt

CAS: 1624602-30-7

Applications 4-((4-(7-Chloroquinolin-4-yl)piperazin-1-yl)sulfonyl)-3-nitroaniline is a VR23 (V767023) related compound. VR23 is a quinoline-sulfonyl hybrid proteasome inhibitor which is used in cancer therapeutics. Targets cancer via cycline E-mediated centrosome.
References Pundir, S. et al.: Canc. Res., 75, 4164 (2015);

Formel: C₁₉H₁₈ClN₅O₄S

Farbe und Form: Neat

Molekulargewicht: 447.9

Ref: TR-C430340

4-((4-(7-Chloroquinolin-4-yl)piperazin-1-yl)sulfonyl)benzene-1,3-diamine

Kontrolliertes Produkt

CAS: 1624602-30-7

Formel: C₁₉H₂₀ClN₅O₂S

Farbe und Form: Neat

Molekulargewicht: 417.912

Ref: TR-C430345

7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8

CAS: 1624602-30-7

7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8 is a compound with unique characteristics that make it suitable for various applications. It is a 3beta-hydroxy steroid additive that offers stability and UV resistance. The amino group in this compound allows for stabilization and catalytic hydrogenation, making it useful in synthesis processes. Additionally, the presence of hydroxy and carbonyl groups enables hydrogen bonding and enhances its catalytic properties. With its diverse range of features, 7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8 is an excellent choice for industries seeking a reliable and efficient compound for their specific needs.

Formel: C₁₉H₈D₈ClN₅O₆S

Reinheit: Min. 95%

Molekulargewicht: 485.93 g/mol

Ref: 3D-ZPC60230